Company Filing History:
Years Active: 2000-2001
Title: Catherine Mader: Innovator in Peptide Synthesis
Introduction
Catherine Mader is a distinguished inventor based in Durham, NC (US). She has made significant contributions to the field of peptide synthesis, holding 2 patents that showcase her innovative methods and compositions.
Latest Patents
Her latest patents focus on methods for the synthesis of peptides, particularly T-20 (also referred to as "DP-178"; SEQ ID NO:1) and T-20-like peptides. These methods utilize both solid and liquid phase synthesis procedures to synthesize and combine specific peptide fragments, yielding the desired peptide. The inventions also detail individual peptide fragments that serve as intermediates in the synthesis process, as well as groups of these fragments that can be utilized together to produce full-length T-20 and T-20-like peptides.
Career Highlights
Catherine Mader is currently associated with Trimeris, Inc., where she continues to advance her research and development in peptide synthesis. Her work has been instrumental in enhancing the understanding and application of peptide technologies.
Collaborations
Catherine has collaborated with notable colleagues, including Myung-Chol Kang and Brian L Bray, contributing to a dynamic research environment that fosters innovation.
Conclusion
Catherine Mader's contributions to peptide synthesis exemplify her commitment to innovation in the field. Her patents not only advance scientific knowledge but also pave the way for future developments in peptide-related applications.